Brexit on the agenda of ‘every meeting’ for EMA during 2018
In its full-year report, the EMA revealed the impact that Brexit had on the agency, including staff numbers and reduced operating capacity.
In its full-year report, the EMA revealed the impact that Brexit had on the agency, including staff numbers and reduced operating capacity.
Infographic
Biopharmaceutical manufacturers in 2017 invested approximately $15.2bn at clinical trial sites around the country – resulting in a total economic impact of more than $42bn, says PhRMA director of public affairs.